[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2641 followers
Created: 2025-07-02 15:32:30 UTC

$IMAB I-Mab shows promising data on Givastomig in combo with immunotherapy in 1L gastric cancer patients at ESMO GI 2025. Phase 1b results are positive.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/Gu3N5lCWIAEa0-8.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940433407454109867/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[combo](/topic/combo)
[promising](/topic/promising)
[$imab](/topic/$imab)

[Post Link](https://x.com/OzmosiHealth/status/1940433407454109867)